Table of contents
seal, a leader in quality management templates, announced today that it has signed an agreement with IMU Biosciences (‘IMU’), a biotechnology company unlocking systems level immune data and AI to advance precision medicine, to provide Electronic Quality Management System (‘eQMS’) services.
This partnership highlights seal’s commitment to enhancing quality and compliance, improving efficiency and supporting innovative companies in medical research.
Integrating seal's eQMS into IMU's operations will help enhance standardisation and efficiency of R&D processes. This QMS is specifically designed to meet IMU's intricate needs, covering aspects from lab documentation and experimental workflows to training programmes. seal’s system facilitates the rigorous documentation and quality control required to pioneer advancements in immune system profiling and precision medicine.
Will Moss, CEO at seal, stated, "Supporting IMU's exciting work in immune system mapping and analysis with our eQMS is an important step for seal. IMU's commitment to understanding the immune system's intricacies, powered by advanced AI and ML analytics, represents exactly the kind of pioneering work seal's platform is designed to enable."
About seal:
seal is a leading provider of R&D, manufacturing, and quality control templates, creating tailored systems to support companies in highly regulated industries. By empowering organisations to digitise and optimise their processes, Seal ensures compliance, efficiency, and data integrity.
Committed to advancing the frontiers of research and development, Seal continually tailors its templates to meet the specific needs and workflows of its partners.
About IMU:
IMU is an innovator in the field of precision immune medicine, dedicated to unlocking the potential of the immune system through deep, systems-level analysis. With its proprietary platform, IMU is pioneering the use of AI and ML analytics to translate vast system level immune data into actionable insights and tools to drive the development of precision medicine across a range of health conditions and treatment responses.